Trial Profile
A Multicentre, Randomised, Double Blind, Double Dummy, Active Comparator Controlled, Parallel Group Study of COLAL-PRED [prednisolone-metasulfobenzoate-sodium] in the Treatment of Moderate Acute Ulcerative Colitis
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Prednisolone metasulfobenzoate sodium (Primary) ; Prednisolone
- Indications Ulcerative colitis
- Focus Adverse reactions; Therapeutic Use
- Sponsors Alizyme
- 02 Nov 2012 Planned number of patients changed from 796 to 890.
- 25 Sep 2009 New trial record.